Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > money questions

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Aug 31, 2022 11:32am

84 Views

Post# 34932440

RE:RE:money questions

StevenBirch wrote: I think you are right Dawg. They have always maintained they had enough to complete Phase II and while Covid and slow enrollment didn't help they have never waivered from that and now I guess they figure they have enough treated and far along enough that it shouldn't be a problem.

That's why these results weren't BTD worthy yet but the trend is important and we should know in a few short months now. Whether it's BTD leading to AA, a JV or warrant money it's all lining up.

Now if we could just get the market to agree.

DJDawg wrote:
I think TLT will need money. I'm shocked they haven't found a JV relationship, unless they are not trying too hard.

Besides a PP, the other money coming in would be from warrants.

Given the evolving CR numbers I'm certain that they will get BTD. Having said that, I could see that they could wait to submit the BTD for when they feel that the numbers are best.

With BTD there would be no doubt of a price pop over 0.5. If so

(See bottom) from the MDA. My read is that:
Oct 3 - price pop over 0.5 brings in 1,582,504 dollars. That may not happen as that is pretty soon.
Jan 9 deadline - price pop of over 0.5 brings in 2,047,578
Price pop over 0.35 anytime till Aug 2024 - brings in 20,124,650

Does this read correctly to you all?
--------

"As of August 29, 2022, there were 64,759,165 warrants outstanding. Each whole warrant entitles the holder thereof to purchase one
additional common share. The warrants are exercisable as follows: 3,165,008 at a price of $0.50 until October 3, 2022, 4,095,157 at
a price of $0.50 until January 9, 2023, and 57,499,000 at a price of $0.35 until August 22, 2024